Dosimetry for fractionated 131I-mIBG therapies in patients with primary resistant high-risk neuroblastoma: preliminary results

被引：0
|
作者：
Buckley, S. [1 ]
Flux, G. [1 ]
Gaze, M. [2 ]
Chittenden, S. [1 ]
Partridge, M. [1 ]
Lancaster, D. [1 ]
Pearson, A. [3 ]
Saran, F. [1 ]
机构：
[1] Royal Marsden NHS Fdn Trust, Sutton, Surrey, England
[2] UCL Hosp, London, England
[3] Inst Canc Res, Sutton, Surrey, England
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2006年 / 33卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：S339 / S339
页数：1
相关论文
共 50 条
  • [31] Dosimetric analysis and clinical outcome for patient with High-Risk Neuroblastoma administered with high-activity therapy of 131I-mIBG
    Cassano, B.
    Polito, C.
    Genovese, E.
    Longo, M.
    Donatiello, S.
    Napolitano, A.
    Insero, T.
    Valeri, S.
    Villani, M. F.
    Castellano, A.
    Garganese, M. C.
    Cannata, V.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (SUPPL 1) : S195 - S196
  • [32] I-131-mIBG therapy in high-risk neuroblastoma patients at end of induction chemotherapy
    Schmidt, M. C.
    Hero, B.
    Decarolis, B.
    Eggert, A.
    Berthold, F.
    Drzezga, A.
    Simon, T.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 : S772 - S772
  • [33] I-131 MIBG AS A FIRST-LINE TREATMENT IN HIGH-RISK NEUROBLASTOMA PATIENTS
    HOEFNAGEL, CA
    DEKRAKER, J
    OLMOS, RAV
    VOUTE, PA
    NUCLEAR MEDICINE COMMUNICATIONS, 1994, 15 (09) : 712 - 717
  • [34] Tandem high-dose 131I-MIBG therapy supported by dosimetry in pediatric patients with relapsed-refractory high-risk neuroblastoma: the Bambino Gesu' Children's Hospital experience
    Altini, Claudio
    Villani, Maria F.
    Di Giannatale, Angela
    Cassano, Bartolomeo
    Pizzoferro, Milena
    Serra, Annalisa
    Castellano, Aurora
    Cannata, Vittorio
    Garganese, Maria C.
    NUCLEAR MEDICINE COMMUNICATIONS, 2022, 43 (02) : 129 - 144
  • [35] Assessment of Organ Dosimetry for Planning Repeat Treatments of High-Dose 131I-MIBG Therapy 123I-MIBG Versus Posttherapy 131I-MIBG Imaging
    Pandit-Taskar, Neeta
    Zanzonico, Pat
    Hilden, Patrick
    Ostrovnaya, Irina
    Carrasquillo, Jorge A.
    Modak, Shakeel
    CLINICAL NUCLEAR MEDICINE, 2017, 42 (10) : 741 - 748
  • [36] Upfront consolidation treatment with 131I-mIbG followed by myeloablative chemotherapy and hematopoietic stem cell transplantation in high-risk neuroblastoma
    Feng, Jianhua
    Cheng, Frankie W. T.
    Leung, Alex W. K.
    Lee, Vincent
    Yeung, Eva W. M.
    Lam, Hoi Ching
    Cheung, Jeanny
    Lam, Grace K. S.
    Chow, Terry T. W.
    Yan, Carol L. S.
    Li, Chi Kong
    PEDIATRIC INVESTIGATION, 2020, 4 (03) : 168 - 177
  • [37] The potential role of pretransplant MIBG diagnostic scintigraphy in targeted administration of 131I-MIBG accompanied by ASCT for high-risk and relapsed neuroblastoma: A pilot study
    Hamidieh, Amir Ali
    Beiki, Davood
    Paragomi, Pedram
    Fallahi, Babak
    Behfar, Maryam
    Fard-Esfahani, Armaghan
    Hosseini, Ashraf Sadat
    Shamshiri, Ahmadreza
    Eftekhari, Mohammad
    Ghavamzadeh, Ardeshir
    PEDIATRIC TRANSPLANTATION, 2014, 18 (05) : 510 - 517
  • [38] Efficacy and Safety of 124I-MIBG Dosimetry-Guided High-Activity 131I-MIBG Therapy of Advanced Pheochromocytoma or Neuroblastoma
    Maric, Ines
    Weber, Manuel
    Prochnow, Andre
    Schmitz, Jochen
    Unger, Nicole
    Schaarschmidt, Benedikt M.
    Poeppel, Thorsten D.
    Rischpler, Christoph
    Bockisch, Andreas
    Herrmann, Ken
    Jentzen, Walter
    Fendler, Wolfgang P.
    JOURNAL OF NUCLEAR MEDICINE, 2023, 64 (06) : 885 - 891
  • [39] Aurora Kinase A inhibition enhances DNA damage and tumor cell death with 131I-MIBG therapy in high-risk neuroblastoma
    Kumar, Prerna
    Koach, Jessica
    Nekritz, Erin
    Mukherjee, Sucheta
    Braun, Benjamin S.
    Dubois, Steven G.
    Nasholm, Nicole
    Haas-Kogan, Daphne
    Matthay, Katherine K.
    Weiss, William A.
    Gustafson, Clay
    Seo, Youngho
    EJNMMI RESEARCH, 2024, 14 (01):
  • [40] Tumor Dosimetry And Radiobiological Study For High-Activity 131I-mIBG Therapy In The Management Of Refractory/Relapsed Neuroblastoma
    Polito, C.
    Cassano, B.
    Genovese, E.
    Longo, M.
    Donatiello, S.
    Insero, T.
    Valeri, S.
    Villani, M. F.
    Castellano, A.
    Garganese, M. C.
    Cannata, V.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (SUPPL 1) : S484 - S484
12345